Prospective association of the Mediterranean diet with cardiovascular disease incidence and mortality and its population impact in a non-Mediterranean population: the EPIC-Norfolk study.
Despite convincing evidence in the Mediterranean region, the cardiovascular benefit of the Mediterranean diet is not well established in non-Mediterranean countries and the optimal criteria for defining adherence are unclear. The population attributable fraction (PAF) of adherence to this diet is also unknown.



In the UK-based EPIC-Norfolk prospective cohort, we evaluated habitual diets assessed at baseline (1993-1997) and during follow-up (1998-2000) using food-frequency questionnaires (n = 23,902). We estimated a Mediterranean diet score (MDS) using cut-points projected from the Mediterranean dietary pyramid, and also three other pre-existing MDSs. Using multivariable-adjusted Cox regression with repeated measures of MDS and covariates, we examined prospective associations between each MDS with incident cardiovascular diseases (CVD) by 2009 and mortality by 2013, and estimated PAF for each outcome attributable to low MDS.



We observed 7606 incident CVD events (2818/100,000 person-years) and 1714 CVD deaths (448/100,000). The MDS based on the Mediterranean dietary pyramid was significantly associated with lower incidence of the cardiovascular outcomes, with hazard ratios (95 % confidence intervals) of 0.95 (0.92-0.97) per one standard deviation for incident CVD and 0.91 (0.87-0.96) for CVD mortality. Associations were similar for composite incident ischaemic heart disease and all-cause mortality. Other pre-existing MDSs showed similar, but more modest associations. PAF due to low dietary pyramid based MDS (<95th percentile) was 3.9 % (1.3-6.5 %) for total incident CVD and 12.5 % (4.5-20.6 %) for CVD mortality.



Greater adherence to the Mediterranean diet was associated with lower CVD incidence and mortality in the UK. This diet has an important population health impact for the prevention of CVD.
MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Tammy Y N
TY
Tong
MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Nicholas J
NJ
Wareham
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Kay-Tee
KT
Khaw
MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Fumiaki
F
Imamura
MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK. nita.forouhi@mrc-epid.cam.ac.uk.
Nita G
NG
Forouhi
D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality; D015331:Cohort Studies; D038441:Diet, Mediterranean; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D011446:Prospective Studies
Arch Intern Med. 2009 Apr 13;169(7):659-69
19364995
Br J Nutr. 2012 Aug;108(4):699-709
22894912
J Nutr. 2009 Jun;139(6):1150-6
19357215
Eur J Nutr. 2002 Dec;41(6):249-57
12474068
Am J Clin Nutr. 2011 Jan;93(1):158-71
21068345
PLoS One. 2012;7(9):e45458
23029021
Lipids. 2010 Oct;45(10):925-39
20397059
Am J Clin Nutr. 2011 Dec;94(6):1458-64
22071704
BMC Med. 2014 Jul 24;12:112
25055810
Stat Med. 2011 Feb 20;30(4):377-99
21225900
Br J Nutr. 2015 Apr 28;113(8):1244-53
25812570
Diabetologia. 2011 Feb;54(2):291-9
20859613
BMJ. 2005 Apr 30;330(7498):991
15820966
J Am Coll Cardiol. 1996 Nov 1;28(5):1103-8
8890801
Am J Clin Nutr. 2009 Dec;90(6):1608-14
19828705
Nutr Metab Cardiovasc Dis. 2011 Apr;21(4):237-44
20096543
Br J Cancer. 1999 Jul;80 Suppl 1:95-103
10466767
J Nutr. 2012 Aug;142(8):1547-53
22739377
Lancet. 2012 Jul 21;380(9838):219-29
22818936
Nutr Metab Cardiovasc Dis. 2013 May;23(5):451-8
22402062
Circulation. 1999 Feb 16;99(6):779-85
9989963
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816
23440795
Int J Epidemiol. 1997;26 Suppl 1:S137-51
9126542
Br J Nutr. 1994 Oct;72(4):619-43
7986792
BMC Med Res Methodol. 2008 Nov 10;8:74
19000303
Br J Nutr. 1995 Apr;73(4):531-50
7794870
Ann Neurol. 2013 Oct;74(4):580-91
23720230
Eur J Nutr. 2014 Aug;53(5):1209-15
24276223
Public Health Nutr. 2011 Dec;14(12A):2274-84
22166184
Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):61-6
18337072
N Engl J Med. 2018 Jun 21;378(25):2441-2442
29897867
Eur J Nutr. 2017 Feb;56(1):421-429
26578528
Diabetes Care. 2011 Jan;34(1):14-9
20929998
Am J Epidemiol. 1999 Mar 15;149(6):531-40
10084242
Br J Nutr. 2014 Jan 14;111(1):151-9
23823619
Lancet. 2010 Feb 27;375(9716):735-42
20167359
Int J Cancer. 2014 Oct 15;135(8):1884-97
24599882
Arch Intern Med. 2005 Apr 25;165(8):929-35
15851646
Am J Clin Nutr. 2008 May;87(5):1414-21
18469266
Eur J Prev Cardiol. 2016 Mar;23(4):400-7
25648935
Am J Clin Nutr. 1995 Jun;61(6 Suppl):1402S-1406S
7754995
Am J Clin Nutr. 2015 Mar;101(3):587-97
25733644
Public Health Nutr. 2014 Dec;17(12):2769-82
24476641
Curr Opin Lipidol. 2014 Feb;25(1):20-6
24370845
Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):733-9
21194913
Nutrition. 2006 Jul-Aug;22(7-8):722-30
16730948
Public Health Nutr. 2003 Jun;6(4):407-13
12795830
BMJ. 2012 Jun 21;344:e4181
22723603
Diabetes Care. 2011 Sep;34(9):1913-8
21788627
Am J Epidemiol. 2012 Dec 15;176(12):1185-92
23186748